Literature DB >> 11505971

Control of autoimmunity by regulatory T cells.

E M Shevach1, R S McHugh, A M Thornton, C Piccirillo, K Natarajan, D H Margulies.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11505971     DOI： 10.1007/978-1-4615-1243-1_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  18 in total

1.  Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

Authors:  Bibiana Bielekova; Marta Catalfamo; Susan Reichert-Scrivner; Amy Packer; Magdalena Cerna; Thomas A Waldmann; Henry McFarland; Pierre A Henkart; Roland Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

2.  Adoptive T Regulatory Cell Therapy for Tolerance Induction.

Authors:  Cecilia Cabello-Kindelan; Shane Mackey; Allison L Bayer
Journal:  Curr Transplant Rep       Date:  2015-06-01

3.  Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.

Authors:  V Di Caro; A D'Anneo; B Phillips; C Engman; J Harnaha; R Lakomy; A Styche; M Trucco; N Giannoukakis
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

4.  Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice.

Authors:  Lillian Maggio-Price; Piper Treuting; Weiping Zeng; Mark Tsang; Helle Bielefeldt-Ohmann; Brian M Iritani
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 5.  CD25+ CD4+ regulatory T-cells in cancer.

Authors:  David C Linehan; Peter S Goedegebuure
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1.

Authors:  Christopher E Touloukian; Wolfgang W Leitner; Rhonda E Schnur; Paul F Robbins; Yong Li; Scott Southwood; Alessandro Sette; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

7.  Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration.

Authors:  Jonathan Kipnis; Michal Cardon; Hila Avidan; Gil M Lewitus; Sharon Mordechay; Asya Rolls; Yael Shani; Michal Schwartz
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

8.  Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer.

Authors:  Lillian Maggio-Price; Piper Treuting; Helle Bielefeldt-Ohmann; Audrey Seamons; Rolf Drivdahl; Weiping Zeng; LapHin Lai; Mark Huycke; Susan Phelps; Thea Brabb; Brian M Iritani
Journal:  Am J Pathol       Date:  2009-01       Impact factor: 4.307

9.  Immunomodulation Followed by Antigen-Specific Treg Infusion Controls Islet Autoimmunity.

Authors:  Cecilia Cabello-Kindelan; Shane Mackey; Alexander Sands; Jennifer Rodriguez; Claudia Vazquez; Alberto Pugliese; Allison L Bayer
Journal:  Diabetes       Date:  2019-11-11       Impact factor: 9.461

10.  Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis.

Authors:  Anne R Gocke; Lori A Lebson; Inna V Grishkan; Lina Hu; Hai M Nguyen; Katharine A Whartenby; K George Chandy; Peter A Calabresi
Journal:  J Immunol       Date:  2012-05-11       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.